{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:11:03Z","timestamp":1793653863431,"version":"4.5.1"},"reference-count":104,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20234Z0014"],"award-info":[{"award-number":["20234Z0014"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473523"],"award-info":[{"award-number":["82473523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1408600"],"award-info":[{"award-number":["23ZR1408600"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jid.2025.12.009","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:17:28Z","timestamp":1769631448000},"page":"1501-1513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4189-8316","authenticated-orcid":false,"given":"Naiting","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7951-3690","authenticated-orcid":false,"given":"Qinyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-563X","authenticated-orcid":false,"given":"Yijie","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1570-3699","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-0550","authenticated-orcid":false,"given":"Leihong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6570","authenticated-orcid":false,"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-5667","authenticated-orcid":false,"given":"Chengfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.12.009_bib1","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1016\/j.cell.2021.06.022","article-title":"NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism","volume":"184","author":"Allouche","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jid.2025.12.009_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.25259\/IJDVL_793_2023","article-title":"Differential expression of serum CXCL9 and CXCL10 levels in vitiligo patients and their correlation with disease severity and stability: a cross-sectional study","volume":"91","author":"Aulakh","year":"2025","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.12.009_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2015.04.008","article-title":"Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: a retrospective study of 159 patients","volume":"73","author":"Bae","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib4","first-page":"51","article-title":"400 cases of vitiligo. A clinico-therapeutic analysis","volume":"17","author":"Behl","year":"1972","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib5","article-title":"Segmental vitiligo distribution follows the underlying arterial blood supply territory: a hypothesis based on anatomo-clinical, pathological and physio-pathological studies","volume":"11","author":"Benzekri","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2025.12.009_bib6","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study","volume":"135","author":"Cavali\u00e9","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12967-024-05113-x","article-title":"Melanocytes in regenerative medicine applications and disease modeling","volume":"22","author":"Coutant","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jid.2025.12.009_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14975","article-title":"Hot spots for clinical signs of disease activity in vitiligo","volume":"33","author":"Delbaere","year":"2024","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.abd.2022.05.001","article-title":"Experimental approaches to assess melanocytes mosaicism in segmental vitiligo","volume":"98","author":"Dellatorre","year":"2023","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-0781.2011.00587.x","article-title":"The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo","volume":"27","author":"Do","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jid.2025.12.009_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bjd\/ljaf143","article-title":"Promoting Repigmentation after Epidermal-cell suspension grafting and preVENTing the loss of melanocytes using topical Ruxolitinib for vitiligo in resistant areas (PREVENT): a prospective monocentric interventional double-blind study","volume":"193","author":"Dugourd","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jocd.13644","article-title":"Serum TWEAK: A cutoff between segmental and nonsegmental vitiligo","volume":"20","author":"El-Taweel","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13368","article-title":"Studying the effect of adding growth factors to the autologous melanocyte keratinocyte suspension in segmental vitiligo","volume":"33","author":"Esmat","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2025.12.009_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2133.2011.10311.x","article-title":"Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients","volume":"165","author":"Ezzedine","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2133.2011.10709.x","article-title":"Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo","volume":"166","author":"Ezzedine","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib16","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.12.009_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2022-001839","article-title":"Global clinicoepidemiological pattern of childhood vitiligo: a systematic review and meta-analysis","volume":"7","author":"Farajzadeh","year":"2023","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.jid.2025.12.009_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.2009.09367.x","article-title":"Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity","volume":"161","author":"Fongers","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/pcmr.70020","article-title":"Neurological mechanisms exploration and therapeutic targets in segmental vitiligo accompanied by white hair","volume":"38","author":"Fu","year":"2025","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.12.009_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","article-title":"Prevalence of vitiligo among adults in the United States","volume":"158","author":"Gandhi","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/apha.12427","article-title":"The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases","volume":"213","author":"Ganea","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.jid.2025.12.009_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/pcmr.13064","article-title":"Varicella-zoster virus in actively spreading segmental vitiligo skin: pathological, immunochemical, and ultrastructural findings (a first and preliminary study)","volume":"36","author":"Gauthier","year":"2023","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.12.009_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/pcmr.12862","article-title":"Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients","volume":"33","author":"Giri","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.12.009_bib24","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/bjd.16352","article-title":"Epidermal melanocytes in segmental vitiligo show altered expression of E-cadherin, but not P-cadherin","volume":"178","author":"Grill","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4103\/ijdvl.IJDVL_704_18","article-title":"Validation of the diagnostic criteria for segmental vitiligo","volume":"86","author":"Gupta","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.12.009_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1067\/mjd.2003.415","article-title":"Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome","volume":"49","author":"Gupta","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0190-9622(96)90718-5","article-title":"Segmental vitiligo: clinical findings in 208 patients","volume":"35","author":"Hann","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib28","article-title":"Local sympathetic nerve depletion does not alter vitiligo progression in a mouse model","volume":"12","author":"Hu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2025.12.009_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2310\/7750.2014.14061","article-title":"Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure","volume":"19","author":"Isedeh","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.12.009_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/pde.15180","article-title":"The co-occurrence of segmental vitiligo and linear morphea in a pediatric patient and a review of the literature","volume":"40","author":"Kahle","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0378-6323.90949","article-title":"Segmental vitiligo: a randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream","volume":"78","author":"Kathuria","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.12.009_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624517","article-title":"Translational research in vitiligo","volume":"12","author":"Katz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.12.009_bib33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4103\/0378-6323.102362","article-title":"A descriptive study to characterize segmental vitiligo","volume":"78","author":"Khaitan","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.12.009_bib34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1365-4362.1998.00557.x","article-title":"Response of segmental vitiligo to 0.05% clobetasol propionate cream","volume":"37","author":"Khalid","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib35","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/jocd.14899","article-title":"Efficacy and safety of traditional and surgical treatment modalities in segmental vitiligo: a review article","volume":"21","author":"Khalili","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5021\/ad.2016.28.2.249","article-title":"A case of segmental vitiligo with generalized morphea stabilized by antimalarial medication","volume":"28","author":"Kim","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ijd.12972","article-title":"Effect of excimer laser treatment on vitiliginous areas with leukotrichia after confirmation by dermoscopy","volume":"55","author":"Kim","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaad.2015.03.036","article-title":"Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: a randomized controlled pilot study","volume":"73","author":"Komen","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/bjd.12725","article-title":"Four compartment method: a simplified and cost-effective method of noncultured epidermal cell suspension for the treatment of vitiligo","volume":"170","author":"Kumar","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/ijd.16090","article-title":"Clinicodemographic features of mixed vitiligo: a case-control study","volume":"61","author":"Kumar","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib41","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-4632.2011.04914.x","article-title":"The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment","volume":"50","author":"Lee","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib42","doi-asserted-by":"crossref","first-page":"764","DOI":"10.5021\/ad.2014.26.6.764","article-title":"Segmental vitiligo and extragenital lichen sclerosus et atrophicus simultaneously occurring on the opposite sides of the abdomen","volume":"26","author":"Lee","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib43","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.jid.2020.06.042","article-title":"RIP1-mediated necroptosis facilitates oxidative stress\u2012induced melanocyte death, offering insight into vitiligo","volume":"141","author":"Li","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib44","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.jid.2022.05.1086","article-title":"Circulating exosomal miR-493-3p affects melanocyte survival and function by regulating epidermal dopamine concentration in segmental vitiligo","volume":"142","author":"Li","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/stcltm\/szae009","article-title":"The treatment of refractory vitiligo with autologous cultured epithelium grafting: a real-world retrospective cohort study","volume":"13","author":"Li","year":"2024","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jid.2025.12.009_bib46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/ijd.17627","article-title":"Segmental vitiligo: autoimmune pathogenesis, neuronal mechanisms, and somatic mosaicism","volume":"64","author":"Lin","year":"2025","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib47","article-title":"Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.12.009_bib48","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/bjd.15569","article-title":"Autologous cell suspension grafting in segmental vitiligo and piebaldism: a randomized controlled trial comparing full surface and fractional CO2 laser recipient-site preparations","volume":"177","author":"Lommerts","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib49","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1111\/jdv.17150","article-title":"A retrospective analysis of 925 cases of segmental vitiligo in a Chinese Han population","volume":"35","author":"Ma","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.12.009_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13408","article-title":"Excimer light therapy in childhood segmental vitiligo: early treatment gives better results","volume":"33","author":"Majid","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2025.12.009_bib51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/bjd.18902","article-title":"Phenotype and function of circulating memory T cells in human vitiligo","volume":"183","author":"Martins","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib52","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2147\/CCID.S467026","article-title":"Treatment of refractory segmental vitiligo and alopecia areata in a child with upadacitinib and NB-UVB: a case report","volume":"17","author":"Mu","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2310\/7750.2006.00018","article-title":"Mixed vitiligo","volume":"10","author":"Mulekar","year":"2006","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.12.009_bib54","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jdv.17108","article-title":"Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review","volume":"35","author":"Narayan","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.12.009_bib55","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/bjd.19661","article-title":"Classification of facial and truncal segmental vitiligo and its clinical courses including recurrence rate and patterns: a retrospective review of 956 patients","volume":"184","author":"Oh","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib56","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pde.14159","article-title":"Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child","volume":"37","author":"Olamiju","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib57","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jid.2021.07.157","article-title":"Increased activation of innate immunity and pro-apoptotic CXCR3B in normal-appearing skin on the lesional site of patients with segmental vitiligo","volume":"142","author":"Passeron","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib58","article-title":"Commentary: local sympathetic nerve depletion does not alter vitiligo progression in a mouse model","volume":"12","author":"Peng","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2025.12.009_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1475-097X.1986.tb00789.x","article-title":"Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man","volume":"6","author":"Pernow","year":"1986","journal-title":"Clin Physiol"},{"key":"10.1016\/j.jid.2025.12.009_bib60","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for Repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/1346-8138.15015","article-title":"Clinical differences between segmental nevus depigmentosus and segmental vitiligo","volume":"46","author":"Roh","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1810","article-title":"Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies","volume":"14","author":"Sant'Anna-Silva","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jid.2025.12.009_bib63","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4103\/ijdvl.IJDVL_790_18","article-title":"Nonsegmental vitiligo follows Blaschko's lines and embryonic pigmentary segments","volume":"86","author":"Sarma","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jid.2025.12.009_bib64","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbrc.2004.01.082","article-title":"Activation\/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo","volume":"315","author":"Schallreuter","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2025.12.009_bib65","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1096\/fj.12-226779","article-title":"Basic evidence for epidermal H2O2\/ONOO(-)-mediated oxidation\/nitration in segmental vitiligo is supported by repigmentation of skin and eyelashes after reduction of epidermal H2O2 with topical NB-UVB-activated pseudocatalase PC-KUS","volume":"27","author":"Schallreuter","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2025.12.009_bib66","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/1523-1747.ep12492612","article-title":"Low catalase levels in the epidermis of patients with vitiligo","volume":"97","author":"Schallreuter","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib67","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/13813455.2020.1739717","article-title":"Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case-control study)","volume":"128","author":"Shabaka","year":"2022","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.jid.2025.12.009_bib68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-0749.2006.00299.x","article-title":"Antioxidant status of segmental and non-segmental vitiligo","volume":"19","author":"Shajil","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jid.2025.12.009_bib69","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5021\/ad.2013.25.2.168","article-title":"A pilot study of 1% pimecrolimus cream for the treatment of childhood segmental vitiligo","volume":"25","author":"Shim","year":"2013","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib70","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/ced.12852","article-title":"Involvement of T cells in early evolving segmental vitiligo","volume":"41","author":"Shin","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib71","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/09546634.2018.1544409","article-title":"Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo","volume":"30","author":"Silpa-Archa","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.12.009_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2011.09.011","article-title":"A pattern of association between clinical form of vitiligo and disease-related variables in a Brazilian population","volume":"65","author":"Silva de Castro","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.12.009_bib73","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/ijd.16844","article-title":"Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review","volume":"62","author":"Souroujon","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib74","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"13","author":"Speeckaert","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jid.2025.12.009_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.568447","article-title":"Autoimmunity in segmental vitiligo","volume":"11","author":"Speeckaert","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.12.009_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: an update on pathophysiology and treatment options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib77","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Ta\u00efeb","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.12.009_bib78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/idoj.IDOJ_154_21","article-title":"Disease stability in segmental and non-segmental vitiligo","volume":"13","author":"Taneja","year":"2022","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jid.2025.12.009_bib79","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/jdv.19162","article-title":"Topical Ruxolitinib: a new treatment for vitiligo","volume":"37","author":"Tavoletti","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.12.009_bib80","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1258\/ebm.2010.009331","article-title":"Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety","volume":"235","author":"Thorsell","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jid.2025.12.009_bib81","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2025.12.009_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.det.2016.11.005","article-title":"Segmental vitiligo","volume":"35","author":"van Geel","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2025.12.009_bib83","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.12013","article-title":"The distribution pattern of segmental vitiligo: clues for somatic mosaicism","volume":"168","author":"van Geel","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib84","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1111\/jdv.19451","article-title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force part 1: towards a new management algorithm","volume":"37","author":"van Geel","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.12.009_bib85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1755-148X.2010.00703.x","article-title":"First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi","volume":"23","author":"van Geel","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.12.009_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdermsci.2016.07.006","article-title":"The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual","volume":"84","author":"Wang","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.12.009_bib87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jid.2009.207","article-title":"Autoantigens in vitiligo identified by the serological selection of a phage-displayed melanocyte cDNA expression library","volume":"130","author":"Waterman","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib88","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-4632.2008.03623.x","article-title":"A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis","volume":"47","author":"Weisberg","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib89","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jid.2021.05.022","article-title":"Immunophenotypic analysis reveals differences in circulating immune cells in the peripheral blood of patients with segmental and nonsegmental vitiligo","volume":"142","author":"Willemsen","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib90","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1607-551X(08)70115-3","article-title":"Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions","volume":"24","author":"Wu","year":"2008","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jid.2025.12.009_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0923-1811(99)00090-0","article-title":"Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions","volume":"23","author":"Wu","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.12.009_bib92","doi-asserted-by":"crossref","first-page":"R240","DOI":"10.1016\/j.cub.2014.02.014","article-title":"Organelle interactions: melanosomes and mitochondria get cozy","volume":"24","author":"Wu","year":"2014","journal-title":"Curr Biol"},{"key":"10.1016\/j.jid.2025.12.009_bib93","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-4632.2009.03852.x","article-title":"Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo","volume":"48","author":"Xu","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","article-title":"Anatomically distinct fibroblast subsets determine skin autoimmune patterns","volume":"601","author":"Xu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jid.2025.12.009_bib94","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/pcmr.13022","article-title":"New insights into segmental vitiligo: a clinical and immunological comparison with nonsegmental vitiligo","volume":"35","author":"Xu","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jid.2025.12.009_bib96","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.4103\/2229-5178.144517","article-title":"Segmental vitiligo with segmental morphea: an autoimmune link?","volume":"5","author":"Yadav","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jid.2025.12.009_bib97","article-title":"Vitiligo skin biomarkers associated with favorable therapeutic response","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.12.009_bib98","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.immuni.2025.05.018","article-title":"Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8+ T cell responses in vitiligo","volume":"58","author":"Yang","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2025.12.009_bib99","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/120347541201600404","article-title":"Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligo","volume":"16","author":"Yu","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jid.2025.12.009_bib100","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2133.2010.10148.x","article-title":"Noninvasive cutaneous blood flow as a response predictor for visible light therapy on segmental vitiligo: a prospective pilot study","volume":"164","author":"Yu","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib101","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/09546634.2017.1303570","article-title":"A combination of Yiqiqubai granule and 308-nm excimer laser in treatment of segmental vitiligo: a prospective study of 233 patients","volume":"28","author":"Zhang","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.12.009_bib102","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.18632\/aging.202472","article-title":"A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jid.2025.12.009_bib103","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5021\/ad.2019.31.4.393","article-title":"Increased circulating CXCL10 in non-segmental vitiligo concomitant with autoimmune thyroid disease and alopecia areata","volume":"31","author":"Zhang","year":"2019","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2025.12.009_bib104","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/ijd.13171","article-title":"Motor nerve conduction velocity is affected in segmental vitiligo lesional limbs","volume":"55","author":"Zhou","year":"2016","journal-title":"Int J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25036772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25036772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T19:52:21Z","timestamp":1780257141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25036772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0022202X25036772"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.12.009","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}